Sorawell-200 Tablets contain Sorafenib 200mg, a targeted cancer therapy medicine used in the treatment of advanced liver cancer (Hepatocellular Carcinoma), kidney cancer (Renal Cell Carcinoma), and thyroid cancer. It works by blocking cancer cell growth and restricting blood supply to tumors. Sorawell-200 is administered orally under the guidance of a healthcare professional.
Brand
Sorawell-200
Composition
Sorafenib 200mg
Form
Oral Tablets
Packaging
30 Tablets
Strength
200 mg
Indications
• Hepatocellular Carcinoma (HCC) – advanced liver cancer
• Renal Cell Carcinoma (RCC) – advanced kidney cancer
• Thyroid Cancer – resistant to radioactive iodine therapy
Key Benefits
• Effective in treating liver, kidney & thyroid cancers
• Inhibits tumor growth and cancer cell multiplication
• Targets and blocks abnormal cancer cell growth
• Easy oral administration
• Trusted formulation from Nextwell Pharmaceutical Pvt Ltd
Sorawell-200 contains Sorafenib 200mg, a targeted cancer therapy medicine used in the treatment of advanced liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and thyroid cancer. It works by blocking cancer cell growth and restricting blood supply to tumors. Sorawell-200 is administered orally under the guidance of a healthcare professional.
Key Benefits of Sorawell-200 (Sorafenib 200mg)
Effective in treating liver, kidney, and thyroid cancers
Inhibits tumor growth and cancer cell multiplication
Trusted formulation from Nextwell Pharmaceutical Pvt Ltd.
Easy oral administration for patient convenience
Targets and blocks abnormal cancer cell growth
Indications
Hepatocellular Carcinoma (HCC) – advanced liver cancer
Renal Cell Carcinoma (RCC) – advanced kidney cancer
Thyroid Cancer – resistant to radioactive iodine therapy
